The MAU (Microalbumin) Rapid Quantitative Test is a diagnostic tool designed to measure microalbumin levels in urine samples with precision and speed. Microalbuminuria occurs when the kidneys leak small amounts of albumin, serving as an early marker of renal dysfunction and vascular endothelial damage.

Biotime’s MAU test offers rapid and reliable quantitative detection, making it valuable for identifying early-stage kidney disease in patients with diabetes, hypertension, and cardiovascular conditions. By enabling timely intervention, the test helps improve patient prognosis and supports better management of renal and metabolic health.

The test delivers results within 10 minutes using only a small urine sample, making it ideal for laboratories, clinics, and point-of-care settings where efficiency and accuracy are essential.